Ignite Creation Date:
2024-05-06 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05881564
Status:
RECRUITING
Last Update Posted:
2023-06-01
First Post:
2023-05-10
Brief Title:
Blood Conservation in Patients 35-12kg Undergoing Congenital Cardiac Surgery
Sponsor:
Augusta University
Organization:
Augusta University
Study Overview
Official Title:
Differences in Outcomes for Patients 35-12kg Undergoing Congenital Cardiac Surgery Who Receive Blood Versus Those Who do Not
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate if there is any clinical difference in patients 35-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None